Novartis India Limited at the Board of Directors of the Company at its meeting held on May 08, 2024 has approved the appointment of Ms. Chandni Maru as the Company Secretary and Key Managerial Personnel of the Company with an immediate effect (from the conclusion of the said Board Meeting held on May 08, 2024). Further, the Board of Directors has also approved appointment of Ms. Chandni Maru as the Compliance Officer of the Company as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Prohibition of Insider Trading) Regulations, 2015, as may be amended from time to time, with an immediate effect. Ms. Chandni Maru is a qualified Company Secretary, and she is an associate member of ICSI having six (6) years of experience in handling compliances of listed and unlisted companies including handling of meetings of Board and general meeting, implementing the corporate governance framework in the listed entities as prescribed under SEBI Laws.

Prior to joining Novartis, she was associated with various law firms like Krishnamurthy and Co. (Klaw), Nishith Desai and Associates and has advised their clients on compliances under Companies Act, SEBI regulations and RBI laws.